To test whether AKT functions as a mediator of GC resistance in IKZF1-deficient BCP-ALL cells, we treated control and IKZF1-/- cells with increasing concentrations of prednisolone in the presence or absence of AKT inhibitor MK2206 (21). This evidence concerns the gene IKZF1 and acute lymphoblastic leukemia.